申请人:Nektar Therapeutics
公开号:US20140323565A1
公开(公告)日:2014-10-30
The invention relates to (among other things) oligomer-calcimimetic conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.
该发明涉及(除其他外)寡聚物-钙敏感受体结合物和相关化合物。该发明的结合物在通过多种给药途径的任何一种给予时,表现出优于先前给予化合物的优点。